TransMedics (NSDQ:TMDX) shares ticked slightly up today on second-quarter results that topped the consensus earnings forecast. The Andover, Mass.-based organ transplant transportation technology developer posted losses of -$8.5 million, or -36¢ per share, on sales of $3.4 million for the three months ended June 30, 2020, for a 7.6% bottom-line gain on a sales decline of […]
coronavirus
Here at MassDevice — medtech's online business journal — we're covering news about the coronavirus (COVID-19) pandemic daily. Here is the latest about coronavirus and the medical device industry, regulatory changes related to the pandemic, new tests for the virus, vaccine development, and much more.
U.S. to spend $1B for doses of J&J’s COVID-19 vaccine candidate
The U.S. Dept. of Health and Human Services and Defense Dept. agreed to a $1 billion deal for a vaccine candidate from Johnson & Johnson (NYSE:JNJ). HHS and DoD announced the agreement with Janssen Pharmaceutical, as the J&J subsidiary is set to offer large-scale manufacturing and the delivery of its COVID-19 vaccine candidate, with the federal […]
Becton Dickinson slides on mixed-bag Q2, declining revenue projections
Becton Dickinson (NYSE:BDX) shares took a big hit today on second-quarter results that were mixed compared to the consensus forecast. BDX shares were down -8.5% at $259.32 in mid-morning trading today. The Franklin Lakes, N.J.-based company posted profits of $286 million, or 97¢ per share, on sales of $3.85 billion for the three months ended June […]
Conformis dips on Q2 losses
Conformis (NSDQ:CFMS) shares dipped today on second-quarter results that highlighted losses influenced by the ongoing COVID-19 pandemic. The Billerica, Mass.-based joint replacement implant maker posted losses of -$2.1 million, or -3¢ per share, on sales of $19.5 million for the three months ended June 30, 2020, for a 68.4% bottom-line gain on a sales decline of […]
ResMed beats Street with boost in ventilator sales
ResMed (NYSE:RMD) shares took a slight hit after hours despite on fourth-quarter results that beat the consensus forecast. The San Diego-based respiratory support device maker posted profits of $177.8 million, or $1.22 per share, on sales of $770.3 million for the three months ended June 30, 2020, for a more than 158% bottom-line gain on sales […]
States band together to purchase BD, Quidel antigen tests for COVID-19
Seven U.S. states have formed an interstate compact with the Rockefeller Foundation to expand the use of rapid point-of-care antigen tests to better manage the COVID-19 pandemic. The compact — announced yesterday by a bipartisan group of governors leading the states — includes Louisiana, Ohio, Maryland, Massachusetts, Michigan, North Carolina and Virginia. The idea is that […]
CHF Solutions sales up 11% in Q2 amid increased COVID-19 demand
CHF Solutions (NSDQ:CHFS) shares took a hit today despite second-quarter revenues that received a boost amid the COVID-19 pandemic. The Eden Prairie, Minn.-based fluid overload treatment developer posted losses of -$3.9 million, or -10¢ per share, on sales of $1.9 million for the three months ended June 30, 2020, for an 11.5% bottom-line gain on sales […]
NuVasive dips despite Street-beating Q2
NuVasive (NSDQ:NUVA) shares closed today on the downturn despite second-quarter results that beat the consensus forecast. The San Diego-based spine surgery technology developer posted losses of -$50 million, or -98¢ per share, on sales of $203.6 million for the three months ended June 30, 2020, for a bottom-line slide from profits of nearly $15 million year-over-year […]
Neuronetics rises on Street-beating Q2
Neuronetics (NSDQ:STIM) shares ticked up today on second-quarter losses that managed to top the consensus forecast. The Malvern, Pa.-based psychiatric disorder treatment developer posted losses of $-7.8 million, or -41¢ per share, on sales of $9.7 million for the three months ended June 30, 2020, for a -9.5% bottom-line slide on a sales decline of -41.2%. […]
New Siemens antibody test can help quantify level of immune response to COVID-19
Siemens Healthineers (ETR: SHL) today announced that it’s secured an FDA emergency use authorization for its SARS-CoV-2 IgG (COV2G) antibody test, which the company touts as the first authorized with semi-quantitative detection. The COV2G test not only provides positive or negative result for IgG antibodies but also reports a numerical result expressed as index value — helping […]
Henry Schein dips on Q2 losses
Henry Schein (NSDQ:HSIC) shares dipped slightly today on second-quarter losses that still managed to top the consensus forecast. The Melville, N.Y.-based medical device maker posted losses of -$13.3 million, or -8¢ per share, on sales of $1.7 billion for the three months ended June 27, 2020, for a bottom-line slide into the red from profits of […]